# Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy

Source: https://onco.cc/trials/nct06107920/  
OnCo record `nct06107920` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in colorectal cancer, run by University Hospital, Rouen, now recruiting.

## Summary

Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy is a phase 3, randomised interventional study registered as NCT06107920 by University Hospital, Rouen, with a registry enrolment figure of 232 participants, started 2024-05-07 and due to reach its primary completion in 2031-08. Interventions recorded: Neoadjuvant chemotherapy. Conditions listed: Colon Cancer. Primary outcome: the success of a full curative therapeutic. Colorectal eligibility wording from the registry: "* Patients with obstructive colon cancer treated by defunctioning stoma". Sites: France. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: COnCERTO
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT06107920
- Phase: 3
- Setting: Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy : A Randomized Phase III Trial - COnCERTO (French 01-18)
- Sponsor: University Hospital, Rouen
- Enrolled: 232

## Sources

- ClinicalTrials.gov NCT06107920: https://clinicaltrials.gov/study/NCT06107920

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06107920.json